Punjab anti-drug campaign: Over 22,000 smugglers held
With this, the number of total drug smugglers arrested in 138 days of the campaign has reached 22,377.
Special DGP (Law and Order) Arpit Shukla stated that over 180 police teams, comprising more than 1,300 police personnel, under the supervision of 93 gazetted officers, conducted raids at as many as 433 locations across the state on Thursday.
The operation led to the registration of 81 FIRs across the state, Shukla said, adding police teams also checked as many as 483 suspicious persons in the exercise.
The state government has also constituted a five-member cabinet subcommittee led by Finance Minister Harpal Singh Cheema to monitor the war against drugs.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
2 hours ago
- Hindustan Times
Yudh Nashian Virudh: 101 peddlers arrested on Day 152 of campaign
Punjab Police on Thursday conducted raids at 380 locations, leading to the arrest of 101 drug smugglers after registration of 79 first information reports (FIRs) across the state, officials said. With this, the number of total drug smugglers arrested, since the state of Yudh Nashian Virudh campaign, has reached 24,089, officials added. With this, the number of total drug smugglers arrested, since the state of Yudh Nashian Virudh campaign, has reached 24,089, Punjab Police officials added. The raids have resulted in the recovery of 778 gm of heroin, 17 quintals of poppy husk, 18,671 intoxicating tablets, capsules and ₹44,710 drug money from the possession of arrested drug smugglers. Special DGP (law and order) Arpit Shukla said that over 180 police teams, comprising over 1,100 police personnel, under the supervision of 82 gazetted officers, conducted raids across the state. 'Police teams have also checked as many as 406 suspicious persons during the day-long operation,' he added. Shukla said that as part of the state government's strategy of enforcement, de-addiction and prevention (EDP), the police have sent 68 persons to undergo rehabilitation treatment.
Mint
5 hours ago
- Mint
Trump slams the door–Don't give in, chart a new trade path, say experts
New Delhi: India should continue to focus on manufacturing for the world, but with a more diversified 'US-plus" export market, even as President Donald Trump's 25% tariff and an unspecified penalty for trade with Russia have bared vulnerabilities, said experts. 'The latest set of tariff announcements has indeed exposed vulnerabilities in export-dependent growth models, necessitating a strategic recalibration of India's manufacturing framework," said Rishi Shah, partner and economic advisory services leader, Grant Thornton Bharat. 'Our 'Make in India' initiative's emphasis on scaling production capacity remains fundamentally sound, but the current trade environment underscores the need for a more nuanced approach centered on innovation-led industrial development." India must now elevate industrial security to the 'same strategic priority we've accorded food security and energy security over the past decades", said Shah. The US is India's largest export market now, followed by the UAE, the Netherlands and the UK. India has been focusing on boosting manufacturing in export-oriented sectors such as mobile phones, automobiles and components, and pharmaceuticals, especially by offering production incentives. This has been complemented by a calibrated import tariff regime that seeks to gradually increase domestic value addition from mere assembly to more complex operations. Policy makers have also been hoping to reap the benefits from a global supply chain recalibration away from China. Fresh US tariffs, however, renew worries that one of the growth engines, net exports, will continue to face headwinds. The 25% tariff on Indian exports from 1 August would mean India's exports would face a higher barrier in the US market than goods from South Korea (15% tariff rate), the EU (15%) and the UK (10%). 'With trade policies being used as tools of influence by major economies, the goal must be of industrial self-reliance," said Shah of Grant Thornton Bharat. 'This isn't about import substitution, rather about building economic resilience against external shocks and policy volatility." Sachchidanand Shukla, group chief economist at Larsen & Toubro Ltd, described the current trade uncertainty as a short-term issue and said the focus on manufacturing-centred development should stay. 'It is true the world is in a flux currently and there has been a degree of de-globalization playing out in the recent past," he said. 'But India has to pursue negotiations with the US, partner with other like-minded economies and economic blocs and get deeply embedded in the global value chains." India should keep eyes trained on harnessing all global opportunities, whether it is within Asia, which is the fastest growing region, the EU or Latin America, and continue to enter into trade deals, said Shukla. According to Shukla, India's push for scaling up domestic manufacturing capabilities has served well in building self-reliance and it should continue, especially for strategic reasons and also for meeting the demand in a growing economy, which has the potential to double its size in six-seven years. Besides, the global trade pie and the opportunity is very large at over $33 trillion and must be tapped to generate jobs and growth, Shukla added. 'The current uncertainty in trade relations with the US is a short-term bump. What has been announced by the US may not be the final outcome, as we have seen in negotiations with other countries. India's focus on manufacturing should continue, and we must make in India and make for the world," Shukla said. The path forward requires a dual approach, said Shah of Grant Thornton Bharat. That involves maintaining India's trajectory of scaling up manufacturing while pivoting toward innovation, said Shah. 'This means deepening our focus on research and development intensity, technological capabilities and knowledge-based value addition across manufacturing, services and emerging technology sectors," said Shah. 'Priority areas include semiconductor design, biotechnology R&D (research and development), pharmaceutical innovation and precision electronics—domains where our MSME ecosystem can leverage advanced technologies to create globally competitive products."
Hindustan Times
12 hours ago
- Hindustan Times
Punjab Police busts illegal opioid supply network; 6 arrested
Chandigarh, Punjab Police on Thursday said it has unearthed an illegal opioid supply network with the arrest of six persons and seized Tramadol tablets from their possession. Punjab Police busts illegal opioid supply network; 6 arrested DGP Gaurav Yadav said that Amritsar Police unearthed the Tramadol supply chain, which originated from a small recovery of 35 tablets in Amritsar and led to a manufacturing unit in Haridwar, Uttarakhand. The breakthrough came following the arrest of a local peddler, Ravinder Singh alias Nikka, in Amritsar. Probing backward and forward linkages, police seized 74,465 Tramadol tablets, 50 Alprazolam tablets, 325 kg of raw material used for manufacturing Tramadol, and ₹7.69 lakh in cash within just 15 days. Yadav said based on sequential disclosures and raids, six arrests were made, which included chemists, distributors, and the plant head of Lucent Biotech Limited. Hari Kishore, plant manager of Lucent Biotech, Roorkee, Bikram, owner-cum-partner of Recall Lifesciences, Roorkee, Manish Kumar Arora, Pooran Jatav, and Kulwinder Singh alias Kinda, a medical store owner at Kathu Nangal in Amritsar district, were among the arrested persons. "The seized strips bore 'government supply only not for sale' tag, raising serious concerns about illegal diversion of medical stock," the DGP said. Some key pharma units found violating norms have been sealed and their records are being scrutinised, the DGP said. Sharing more details, Amritsar Commissioner Gurpreet Singh Bhullar said a joint team of Amritsar Police and drug inspectors raided some pharma units in Roorkee, seizing 4,130 unlabelled Tramadol tablets and 325 kg of unregistered raw material. This was in addition to the earlier recovery of more than 70,000 tablets and ₹7.69 lakh in cash, he said. Bhullar said during interrogation, Hari Kishore admitted to printing 'government supply only not for sale' tags on the strips of 'TRAKEM-100' Tramadol tablet strips at the manufacturing unit. The accused also admitted that Tramadol tablets manufactured for another legal firm were sold illegally to Recall Lifesciences, Bhullar said. More persons involved in the racket have been identified and raids are being conducted to arrest them. This article was generated from an automated news agency feed without modifications to text.
